Daytrana and application site vesicles Patient Reports February 13, 2012

Daytrana Side Effects Report #5366058-0
Daytrana side effect was reported by a Physician from UNITED STATES on Dec 21, 2006. Male patient was diagnosed with psychomotor hyperactivity and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site dermatitis, application site vesicles. Daytrana dosage: 20 MG EVERY MORNING, TRANSDERMAL. Patient recovered.

Daytrana Side Effects Report #5159019-8
Daytrana side effect was reported by a Physician from UNITED STATES on Nov 14, 2006. Female patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site vesicles, rash erythematous. Daytrana dosage: 20 MG, TRANSDERMAL; 10 MG TRANSDERMAL. During the same period patient was treated with PROZAC, ADDERALL. Patient recovered.

Daytrana Side Effects Report #5494140-6
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Male patient, child 8 years of age, weighting 104.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site erythema, application site excoriation, application site pruritus, application site vesicles, investigation abnormal, scarlet fever. Daytrana dosage: 20 MG, 1X/DAY: QD,TRANSDERMAL. Patient recovered.

Daytrana Side Effects Report #5554858-3
Daytrana side effect was reported by a Physician from UNITED STATES on Nov 26, 2007. Male patient, 14 years of age, weighting 85.98 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site erythema, application site irritation, application site pruritus, application site vesicles, off label use, sepsis . Daytrana dosage: 10 MG, 1X DAY: QD, TRANSDERMAL. Patient was hospitalized. Patient recovered.


Daytrana Side Effects Report #5452085-1
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, child 10 years of age, weighting 84.88 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site bleeding, application site vesicles, urticaria. Daytrana dosage: 10 MG, TRANSDERMAL. Patient recovered.

Daytrana Side Effects Report #5319819-8
Daytrana side effect was reported by a Physician from UNITED STATES on Dec 21, 2006. Male patient was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site dermatitis, application site vesicles. Daytrana dosage: 20 MG EVERY MORNING, TRANSDERMAL. Patient recovered.

Daytrana Side Effects Report #5452087-5
Daytrana side effect was reported by a Health Professional from UNITED STATES on June 04, 2007. Male patient, child 11 years of age, weighting 114.0 lb, was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site bleeding, application site rash, application site vesicles. Daytrana dosage: 15MG, TRANSDERMAL; 10 MG, TRANSDERMAL. During the same period patient was treated with RISPERDAL, CLONIDINE. Patient recovered.